Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk

[MargaretAlice]

Spent part of last week at MD Anderson, eval by MO. Recommendation was the ATEMPT clinical trial.

I am very interested in immunotherapy. If I had qualified, I was there at the right time to put my name in the hat. The clinical nurse supporting the MO was also closely following the upcoming NeuVax trial. I think we chimed in together on the 4 positive node requirement, eliminated another patient from consideration. Mittendorf's research nurse suggested I watch for any info published about a different vaccine, "AE37".